Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722008 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
ElectronicAdd to Basket
Site LicenseAdd to Basket



Chinese Pharmaceutical Industry
Access China Management Consulting Ltd, May 2009, Pages: 41


  Description  
  Table of Contents  
  Companies Mentioned  
    
    
   
 Enquire before Buying  
 Send to a Friend  

The Chinese pharmaceutical industry has increased with an annual average growth rate of 16.72% over the last few decades. However, the industry is still small-scale, with a scattered geographical layout, duplicated production processes, and outdated manufacturing technology and management structure. The Chinese pharmaceutical industry also has a lower market concentration and weak international trading competitiveness, coupled with a lack of patented pharmaceuticals developed in-house. Gaining access to the WTO will further integrate the Chinese economy into the global economic environment, and Chinese pharmaceutical enterprises will face a huge challenge.

China's entry into the WTO, in December of 2001, opened the door to a lucrative market for foreign companies, and especially for pharmaceutical manufacturers and distributors. Accession to the WTO will bind China by fundamental WTO principles, such as improved transparency and the strengthening of commercial legal procedures. China's WTO commitments also include the tightening of rules on intellectual property, tariff concessions, and permission of foreign distributors' entry into domestic market. These commitments will help reduce the risk of doing business in China and encourage increased flow of trade and investment, enhancing the business opportunities for international pharmaceutical companies and investors.

This study provides a comprehensive analysis of the multifaceted pharmaceutical industry and market, based on full and accurate statistics, help guide non-Chinese companies and investors through the many changes transforming the Chinese pharmaceutical sector.


Customers who bought this item also bought

Pharmaceutical Industry in China

Business Opportunities in China: The Impact of the WTO – 2nd Edition

China’s Attraction and Strategies to Work with It: Analysis of Best Strategies for Western Pharmaceutical and Biotech Companies to Partner with Chinese Pharmaceutical Companies

Chinese Pharmaceutical Industry: Strategies, Trends and Opportunities

Latest Chinese Regulations for Imported Drug Registration: A Comprehensive Guidebook for Foreign Pharmaceutical Companies China Pharmaceutical Guidebook Series (1) (3rd edition)

Chinese Markets for Pharmaceutical Packaging

In-Depth Analysis of the China Pharmaceutical Market

China Pharmaceutical Industry: Analysis and Market Trends

The Pharmaceutical Market: China

Pharmaceutical Industry in China - PEST Framework Analysis

China's Pharmaceutical Industry - Porter's Five Forces Strategy Analysis

2008 Report for the Investigation of the Chinese Medical and Pharmaceutical CRO Market



Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds